Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: Meta-analysis of postprogression survival for first-line chemotherapy

被引:0
|
作者
Kasuga, Akiyoshi [1 ]
Hamamoto, Yasuo [1 ]
Takeuchi, Ayano [2 ]
Kawasaki, Kenta [1 ]
Suzuki, Takeshi [1 ]
Hirata, Kenro [1 ]
Sukawa, Yasutaka [1 ]
Takaishi, Hiromasa [1 ]
Kanai, Takanori [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1718
引用
收藏
页码:257 / 257
页数:1
相关论文
共 50 条
  • [1] Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy
    Kasuga, Akiyoshi
    Hamamoto, Yasuo
    Takeuchi, Ayano
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Sukawa, Yasutaka
    Takaishi, Hiromasa
    Kanai, Takanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) : 595 - 602
  • [2] Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy
    Akiyoshi Kasuga
    Yasuo Hamamoto
    Ayano Takeuchi
    Kenta Kawasaki
    Takeshi Suzuki
    Kenro Hirata
    Yasutaka Sukawa
    Hiromasa Takaishi
    Takanori Kanai
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 595 - 602
  • [3] Meta-analysis of postprogression survival for first-line gemcitabine monotherapy in patients with advanced pancreatic cancer: Positive relationship between subsequent anti-cancer therapy and overall survival.
    Kasuga, Akiyoshi
    Hamamoto, Yasuo
    Takeuchi, Ayano
    Kawasaki, Kenta
    Suzuki, Takeshi
    Hirata, Kenro
    Sukawa, Yasutaka
    Takaishi, Hiromasa
    Kanai, Takanori
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] POSTPROGRESSION SURVIVAL FOR FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Kawakami, H.
    Okamoto, I.
    Hayashi, H.
    Taguri, M.
    Morita, S.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 95 - 95
  • [5] Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer
    Kawakami, Hisato
    Okamoto, Isamu
    Hayashi, Hidetoshi
    Taguri, Masataka
    Morita, Satoshi
    Nakagawa, Kazuhiko
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 3003 - 3009
  • [6] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [7] Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
    Buyse, M
    Thirion, P
    Carlson, RW
    Burzykowski, T
    Molenberghs, G
    Piedbois, P
    LANCET, 2000, 356 (9227): : 373 - 378
  • [8] PROGRESSION-FREE SURVIVAL AND POSTPROGRESSION SURVIVAL IN PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY
    Shitara, K.
    Matsuo, K.
    Muro, K.
    Ohtsu, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 232 - 232
  • [9] Effect of subsequent chemotherapy on overall survival in first-line chemotherapy with targeted agents for patients with metastatic colorectal cancer: Systematic review and meta-analysis of randomized control trials.
    Sakai, Daisuke
    Kudo, Toshihiro
    Kato, Aya
    Sueda, Toshinori
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [10] Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
    Hayashi, H.
    Okamoto, I.
    Morita, S.
    Taguri, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1537 - 1541